<DOC>
	<DOCNO>NCT00357539</DOCNO>
	<brief_summary>To compare ocular tolerance , safety ocular pharmacokinetics 3 concentration ( 0.5 % - 1.0 % - 1.5 % ) vehicle T1225 .</brief_summary>
	<brief_title>Safety Ocular Pharmacokinetics After 1 Drop T1225 0.5 , 1 1.5 % 48 Healthy Volunteers</brief_title>
	<detailed_description>The present phase I clinical trial perform order investigate ocular tolerance , safety ocular pharmacokinetics single administration T1225 eye drop ( 0.5 % , 1.0 % , 1.5 % ) healthy volunteer .</detailed_description>
	<mesh_term>Bacterial Infections</mesh_term>
	<mesh_term>Eye Infections</mesh_term>
	<mesh_term>Eye Infections , Bacterial</mesh_term>
	<criteria>Male female age 18 45 year old ; Written inform consent ; Healthy volunteer ( without ocular symptom ) ; Normal ocular examination eye ( correct visual acuity ( VA ) &gt; = 6/10 slit lamp examination without clinical relevant abnormality tear breakup time ( BUT ) &gt; = 10 second lachrymal secretion Schirmer test &gt; = 10 mm 5 minute lissamine green test total score &lt; 4 ) . Ocular trauma , infection inflammation within last 3 month ; Conjunctival hyperaemia score &gt; = 2 , water score &gt; = 2 , folliculopapillary conjunctivitis score &gt; = 2 , number fluoresceinstained punctuation &gt; = 10 ; Blepharitis , conjunctivitis , uveitis ; Ocular laser treatment within last 3 month ; Ocular surgery , include LASIK PRK , within last 12 month ; Topical ocular treatment last month ; Ocular antibiotic within last 7 day ; Medication study ( except paracetamol contraceptive ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>July 2006</verification_date>
</DOC>